Cargando…

Incidence and predictors of left atrial thrombus in patients with atrial fibrillation prior to ablation in the real world of China

BACKGROUND: The present study was to evaluate the value of CHADS2 and CHA2DS2VASC scores on predicting left atrial (LA) or left atrial appendage (LAA) thrombus in atrial fibrillation (AF) patients prior to ablation in the real world of China. METHODS AND RESULTS: A total of 397 patients with non-val...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Fengpeng, Tian, Yongyue, Lei, Sen, Yang, Yuan, Luo, Suxin, He, Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697491/
https://www.ncbi.nlm.nih.gov/pubmed/30685313
http://dx.doi.org/10.1016/j.ipej.2019.01.005
_version_ 1783444392553480192
author Jia, Fengpeng
Tian, Yongyue
Lei, Sen
Yang, Yuan
Luo, Suxin
He, Quan
author_facet Jia, Fengpeng
Tian, Yongyue
Lei, Sen
Yang, Yuan
Luo, Suxin
He, Quan
author_sort Jia, Fengpeng
collection PubMed
description BACKGROUND: The present study was to evaluate the value of CHADS2 and CHA2DS2VASC scores on predicting left atrial (LA) or left atrial appendage (LAA) thrombus in atrial fibrillation (AF) patients prior to ablation in the real world of China. METHODS AND RESULTS: A total of 397 patients with non-valvular AF were analyzed to determine the relationship between CHADS2 and CHA2DS2VASC scores and LA/LAA thrombus identified on transesophageal echocardiography prior to radiofrequency ablation(RFA). LA/LAA thrombus was present in 38 patients (9.6%). There was a strong association between higher CHADS2 score or CHA2DS2VASC score and LA/LAA thrombus. No thrombus was identified in patients with CHA2DS2VASC score of 0 regardless of anticoagulation status. However, LA/LAA thrombus was detected in 2.9% patients with CHADS2 score of 0 without adequate anticoagulation, while no thrombus was present in the patients with CHADS2 score of 0 with adequate anticoagulation. Univariate analysis showed that heart failure (LVEF<50%), LA≥40 mm, diabetes mellitus, previous stroke or TIA, CAD, hypertension, inadequate anticoagulation therapy, CHADS2 score of ≥2 and CHA2DS2VASC score of ≥2 were significantly associated with LA/LAA thrombus. Multivariable Cox regression analysis demonstrated that CHA2DS2VASC score of ≥2 (p = 0.02) and previous stroke or TIA (p = 0.04) were independently associated with LA/LAA thrombus regardless of anticoagulation status. ROC curve analysis showed that higher CHADS2 score and CHA2DS2VASC score could be similarly used to predict the presence of LA thrombus. CONCLUSIONS: Both higher CHA2DS2VASC and CHADS2 scores were associated with LA/LAA thrombus in non-valvular AF patients prior to ablation. Although CHA2DS2VASC score and CHADS2 score had similar value to predict LA/LAA thrombus, CHA2DS2VASc score was better to identify low-risk patients for LA/LAA thrombus than CHADS2 score without anticoagulation. There will be a possibility of performing AF ablation or cardioversion in patients with a CHA2DS2VASC of 0 without TEE or anticoagulation therapy. The safety need to be verified by more multicentre randomized controlled clinical trails.
format Online
Article
Text
id pubmed-6697491
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-66974912019-08-19 Incidence and predictors of left atrial thrombus in patients with atrial fibrillation prior to ablation in the real world of China Jia, Fengpeng Tian, Yongyue Lei, Sen Yang, Yuan Luo, Suxin He, Quan Indian Pacing Electrophysiol J Original Article BACKGROUND: The present study was to evaluate the value of CHADS2 and CHA2DS2VASC scores on predicting left atrial (LA) or left atrial appendage (LAA) thrombus in atrial fibrillation (AF) patients prior to ablation in the real world of China. METHODS AND RESULTS: A total of 397 patients with non-valvular AF were analyzed to determine the relationship between CHADS2 and CHA2DS2VASC scores and LA/LAA thrombus identified on transesophageal echocardiography prior to radiofrequency ablation(RFA). LA/LAA thrombus was present in 38 patients (9.6%). There was a strong association between higher CHADS2 score or CHA2DS2VASC score and LA/LAA thrombus. No thrombus was identified in patients with CHA2DS2VASC score of 0 regardless of anticoagulation status. However, LA/LAA thrombus was detected in 2.9% patients with CHADS2 score of 0 without adequate anticoagulation, while no thrombus was present in the patients with CHADS2 score of 0 with adequate anticoagulation. Univariate analysis showed that heart failure (LVEF<50%), LA≥40 mm, diabetes mellitus, previous stroke or TIA, CAD, hypertension, inadequate anticoagulation therapy, CHADS2 score of ≥2 and CHA2DS2VASC score of ≥2 were significantly associated with LA/LAA thrombus. Multivariable Cox regression analysis demonstrated that CHA2DS2VASC score of ≥2 (p = 0.02) and previous stroke or TIA (p = 0.04) were independently associated with LA/LAA thrombus regardless of anticoagulation status. ROC curve analysis showed that higher CHADS2 score and CHA2DS2VASC score could be similarly used to predict the presence of LA thrombus. CONCLUSIONS: Both higher CHA2DS2VASC and CHADS2 scores were associated with LA/LAA thrombus in non-valvular AF patients prior to ablation. Although CHA2DS2VASC score and CHADS2 score had similar value to predict LA/LAA thrombus, CHA2DS2VASc score was better to identify low-risk patients for LA/LAA thrombus than CHADS2 score without anticoagulation. There will be a possibility of performing AF ablation or cardioversion in patients with a CHA2DS2VASC of 0 without TEE or anticoagulation therapy. The safety need to be verified by more multicentre randomized controlled clinical trails. Elsevier 2019-01-25 /pmc/articles/PMC6697491/ /pubmed/30685313 http://dx.doi.org/10.1016/j.ipej.2019.01.005 Text en © 2019 Indian Heart Rhythm Society. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Jia, Fengpeng
Tian, Yongyue
Lei, Sen
Yang, Yuan
Luo, Suxin
He, Quan
Incidence and predictors of left atrial thrombus in patients with atrial fibrillation prior to ablation in the real world of China
title Incidence and predictors of left atrial thrombus in patients with atrial fibrillation prior to ablation in the real world of China
title_full Incidence and predictors of left atrial thrombus in patients with atrial fibrillation prior to ablation in the real world of China
title_fullStr Incidence and predictors of left atrial thrombus in patients with atrial fibrillation prior to ablation in the real world of China
title_full_unstemmed Incidence and predictors of left atrial thrombus in patients with atrial fibrillation prior to ablation in the real world of China
title_short Incidence and predictors of left atrial thrombus in patients with atrial fibrillation prior to ablation in the real world of China
title_sort incidence and predictors of left atrial thrombus in patients with atrial fibrillation prior to ablation in the real world of china
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697491/
https://www.ncbi.nlm.nih.gov/pubmed/30685313
http://dx.doi.org/10.1016/j.ipej.2019.01.005
work_keys_str_mv AT jiafengpeng incidenceandpredictorsofleftatrialthrombusinpatientswithatrialfibrillationpriortoablationintherealworldofchina
AT tianyongyue incidenceandpredictorsofleftatrialthrombusinpatientswithatrialfibrillationpriortoablationintherealworldofchina
AT leisen incidenceandpredictorsofleftatrialthrombusinpatientswithatrialfibrillationpriortoablationintherealworldofchina
AT yangyuan incidenceandpredictorsofleftatrialthrombusinpatientswithatrialfibrillationpriortoablationintherealworldofchina
AT luosuxin incidenceandpredictorsofleftatrialthrombusinpatientswithatrialfibrillationpriortoablationintherealworldofchina
AT hequan incidenceandpredictorsofleftatrialthrombusinpatientswithatrialfibrillationpriortoablationintherealworldofchina